Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms

Genes Chromosomes and Cancer

Volumn 37, Issue 4, 2003, Pages 421-426

  Steinemann, Doris ^a   Gesk, Stefan ^b   Zhang, Yanming ^c   Harder, Lana ^b   Pilarsky, Christian ^d   Hinzmann, Bernd ^e   Martin Subero, Jose Ignacio ^b   Calasanz, Maria Jose ^f   Mungall, Andrew ^g   Rosenthal, André ^e   Siebert, Reiner ^b   Schlegelberger, Brigitte ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e MetaGen Gesell Genomforschung mbH   (Germany)

^f UNIVERSITY OF NAVARRA   (Spain)

^g WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CHROMOSOME 6Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; HUMAN; HUMAN CELL; LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; YEAST ARTIFICIAL CHROMOSOME;

CELL LINE, TRANSFORMED; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHOMA, B-CELL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0038461936     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10231     Document Type: Article

References (35)

1. Abe T, Makino N, Furukawa T, Ouyang H, Kimura M, Yatsuoka T, Yokoyama T, Inoue H, Fukushige S, Hoshi M, Hayashi Y, Sunamura M, Kobari M, Matsuno S, Horii A. 1999. Identification of three commonly deleted regions on chromosome arm 6q in human pancreatic cancer. Genes Chromosomes Cancer 25:60-64.
2. Acquati F, Morelli C, Cinquetti R, Bianchi MG, Porrini D, Varesco L, Gismondi V, Rocchetti R, Talevi S, Possati L, Magnanini C, Tibiletti MG, Bernasconi B, Daidone MG, Shridhar V, Smith DI, Negrini M, Barbanti-Brodano G, Taramelli R. 2001. Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27. Oncogene 20:980-988.
3. Baron BW, Anastasi J, Thirman MJ, Furukawa Y, Fears S, Kim DC, Simone F, Birkenbach M, Montag A, Sadhu A, Zeleznik-Le N, McKeithan TW. 2002. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc Natl Acad Sci USA 99:2860-2865.
4. Baylin SB, Herman JG. 2000. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16:168-174.
5. Cossman J, Annunziata CM, Barash S, Staudt L, Dillon P, He WW, Ricciardi-Castagnoli P, Rosen CA, Carter KC. 1999. Reed-Sternberg cell genome expression supports a B-cell lineage. Blood 94:411-416.
6. Gaidano G, Hauptschein RS, Parsa NZ, Offit K, Rao PH, Lenoir G, Knowles DM, Chaganti RS, Dalla-Favera R. 1992. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood 80:1781-1787.
7. Harland L, Crombie R, Anson S, deBoer J, Ioannou PA, Antoniou M. 2002. Transcriptional regulation of the human TATA binding protein gene. Genomics 79:479-482.
8. Hauptschein RS, Gamberi B, Rao PH, Frigeri F, Scotto L, Venkatray VS, Gaidano G, Rutner T, Edwards YH, Chaganti RSK, Dalla-Favera R. 1998. Cloning and mapping of human chromosome 6q26-q27 deleted in B-cell non-Hodgkin lymphoma and multiple tumor types. Genomics 50:170-186.
9. Hauptschein RS, Gaudano G, Rao PH, Scotto L, Edwards YH, Chaganti RSK, Dalla-Favera R. 2000. An apparent interlocus gene conversion-like event at a putative tumor suppressor gene locus on human chromosome 6q27 in a Burkitt's lymphoma cell line. DNA Res 7:261-272.
10. Jones PA, Laird PW. 1999. Cancer epigenetics comes of age. Nat Genet 21:163-167.
11. Kawakami T, Furukawa Y, Sudo K, Saito H, Takami S, Takahashi E, Nakamura Y. 1995. Isolation and mapping of human gene (PDCD2) that is highly homologous to Rp8, a rat gene associated with programmed cell death. Cytogenet Cell Genet 71:41-43.
12. Lin H, Morin PJ. 2001. A novel homozygous deletion at chromosomal band 6q27 in an ovarian cancer cell line delineates the position of a putative tumor suppressor gene. Cancer Lett 173:63-70.
13. Liu Y, Emilion G, Mungall AJ, Dunham I, Beck S, Le Meuth-Metzinger VG, Shelling AN, Charnock FM, Ganesan TS. 2002. Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer. Oncogene 21:387-399.
14. Lutterbach B, Sun D, Schuetz J, Hiebert SW. 1998. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol Cell Biol 18:3604-3611.
15. Merup M, Moreno TC, Heyman M, Rönnberg K, Grandér D, Detlofsson R, Rasool O, Liu Y, Söderhäll S, Juliusson G, Gahrton G, Einhorn S. 1998. 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas. Blood 91:3397-3400.
16. Minaguchi T, Matsushima M, Saito S, Kanamori Y, Shirahama S, Okamoto S, Minami M, Taketani Y, Nakamura Y. 1999. Complete DNA sequence and characterisation of a 330-kb VNTR-rich region on chromosome 6q27 that is commonly deleted in ovarian cancer. DNA Res 6:131-136.
17. Nutt SL, Vambrie S, Steinlein P, Kozmik Z, Rolink A, Weith A, Busslinger M. 1999. Independent regulation of the two Pax5 alleles during B-cell development. Nat Genet 21:390-395.
18. Offit K, Jhanwar SC, Ladanyi M, Filippa DA, Chaganti RSK. 1991. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology and exposure to cytotoxic treatment. Genes Chromosomes Cancer 3:189-201.
19. Offit K, Parsa NZ, Gaidano G, Filippa DA, Louie D, Pan D, Jhanwar SC, Dalla-Favera R, Chaganti RS. 1993. 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 82:2157-2162.
20. Offit K, Louie DC, Parsa NZ, Filippa D, Gangi M, Siebert R, Chaganti RS. 1994. Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23). Blood 83:2611-2618.
21. Owens GP, Hahn WE, Cohen JJ. 1991. Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol Cell Biol 11:4177-4188.
22. Rodriguez C, Causse A, Ursule E, Theillet C. 2000. At least five regions of imbalance on 6q in breast tumors, losses, and gains. Genes Chromosomes Cancer 27:76-84.
23. Saito S, Sirahama S, Matsushima M, Suzuki M, Sagae S, Kudo R, Saito J, Noda K, Nakumara Y. 1996. Definition of a commonly deleted region in ovarian cancers to a 300-kb segment of chromosome 6q27. Cancer Res 56:5586-5589.
24. Scarr RB, Sharp PA. 2002. PDCD2 is a negative regulator of HCF-1 (C1). Oncogene 21:5245-5254.
25. Schmitt AO, Specht T, Beckmann G, Dahl E, Pilarsky CP, Hinzmann B, Rosenthal A. 1999. Exhaustive mining of EST libraries for genes differentially expressed in normal and tumour tissues. Nucleic Acids Res 27:4251-4260.
26. Shibata MA, Liu ML, Knudson MC, Shibata E, Yoshidome K, Bandey T, Korsmeyer SJ, Green JE. 1999. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-Tag transgenic mice: reduction in protective apoptotic response at the preneoplastic stage. EMBO J 18:2692-2701.
27. Shridhar V, Staub J, Huntley B, Cliby W, Jenkins R, Pass HI, Hartmann L, Smith DI. 1999. A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer. Oncogene 18:3913-3918.
28. Siebert R, Pilarsky C, Zhang Y, Hinzmann B, Matthiesen P, Harder S, Rosenthal A, Schlegelberger B. 2000. Deletion mapping and electronic expression profiling in 6q for identification of candidate tumor suppressor genes involved in the pathogenesis of lymphoid neoplasms. Cytogenet Cell Genet 88:189.
29. Suzuki M, Saito S, Saga Y, Ohwada M, Sato I. 1998. Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer. Med Oncol 15:119-123.
30. Theile M, Seitz S, Arnold W, Jandrik B, Frege R, Schlag M, Haensch W, Guski H, Winzer K, Barrett JC, Scherneck S. 1996. A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene 13:677-685.
31. Tibiletti MG, Truba M, Ponti E, Sessa L, Acquati F, Furlan D, Bernasconi B, Fichera M, Mihalich A, Ziegler A, Volz A, Facco C, Riva C, Cremonesi L, Ferrari M, Taramelli R. 1998. Physical map of the D6S149-D6S193 region on chromosome 6q27 and its involvement in benign surface epithelial ovarian tumours. Oncogene 16:1639-1642.
32. Tibiletti MG, Sessa F, Bernasconi B, Cerutti R, Broggi B, Furlan D, Acquati F, Bianchi M, Russo A, Capella C, Taramelli R. 2000. A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast. Clin Cancer Res 6:1422-1431.
33. Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, Monconduit M, Bastard C. 1994. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 84:1043-1049.
34. Trent JM, Stanbridge EJ, McBride HL, Meese EU, Casey G, Araujo DE, Witkowsky CM, Nagle RB. 1990. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 247:568-571.
35. Zhang Y, Matthiesen P, Harder S, Siebert R, Castoldi G, Calasanz MJ, Wong KF, Rosenwald A, Ott G, Atkin NB, Schlegelberger B. 2000. A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer 27:52-58.